类风湿关节炎的诊断与治疗:走向最佳实践。类风湿关节炎的精准医学研究[j]。

Clinical calcium Pub Date : 2018-01-01 DOI:CliCa1805626629

Katsuya Suzuki, Tsutomu Takeuchi

{"title":"类风湿关节炎的诊断与治疗:走向最佳实践。类风湿关节炎的精准医学研究[j]。","authors":"Katsuya Suzuki, Tsutomu Takeuchi","doi":"CliCa1805626629","DOIUrl":null,"url":null,"abstract":"Biologics made a big paradigm shift in the treatment for rheumatoid arthritis(RA). In the next step, current research for RA shifts from traditional approach for average patients to precision medicine using huge omics data from patients. Multiomics analysis for the specimen from patients will play an important role for the establishment of precision medicine for RA.","PeriodicalId":10389,"journal":{"name":"Clinical calcium","volume":"28 5","pages":"626-629"},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis.]\",\"authors\":\"Katsuya Suzuki, Tsutomu Takeuchi\",\"doi\":\"CliCa1805626629\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Biologics made a big paradigm shift in the treatment for rheumatoid arthritis(RA). In the next step, current research for RA shifts from traditional approach for average patients to precision medicine using huge omics data from patients. Multiomics analysis for the specimen from patients will play an important role for the establishment of precision medicine for RA.\",\"PeriodicalId\":10389,\"journal\":{\"name\":\"Clinical calcium\",\"volume\":\"28 5\",\"pages\":\"626-629\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical calcium\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/CliCa1805626629\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical calcium","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/CliCa1805626629","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

摘要

生物制剂使类风湿关节炎(RA)的治疗模式发生了重大转变。下一步，目前对RA的研究将从针对普通患者的传统方法转向使用来自患者的大量组学数据的精准医学。对患者标本进行多组学分析，将对类风湿关节炎精准医学的建立起到重要作用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

[Diagnosis and treatment of rheumatoid arthritis:toward the best practice. Towards precision medicine in rheumatoid arthritis.]

Biologics made a big paradigm shift in the treatment for rheumatoid arthritis(RA). In the next step, current research for RA shifts from traditional approach for average patients to precision medicine using huge omics data from patients. Multiomics analysis for the specimen from patients will play an important role for the establishment of precision medicine for RA.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Clinical calcium

自引率

0.00%

发文量